Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Santhera Pharmaceuticals Holding AG
SANNCurrent price
13.24 CHF
+0.42 CHF (+3.28%)
Last closed
12.32 CHF
Company
www.santhera.com
ISIN
CH0027148649
Sector
Healthcare
Industry
Biotechnology
Exchange
SIX Swiss Exchange
Capitalization
101 710 417 CHF
Yield for 12 month
+31.35 %
1Y
3Y
5Y
10Y
15Y
SANN
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland. Address: Hohenrainstrasse 24, Pratteln, Switzerland, 4133
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22.82 CHFP/E ratio
1.47Dividend Yield
–Current Year
+102 821 471 CHF
Last Year
+7 430 182 CHF
Current Quarter
+14 033 131 CHF
Last Quarter
+7 016 566 CHF
Current Year
+99 605 006 CHF
Last Year
+3 858 764 CHF
Current Quarter
+11 440 571 CHF
Last Quarter
+4 424 005 CHF
Key Figures SANN
1 year
3 years
5 years
10 years
EBITDA
56 945 838 CHF
Operating Margin TTM
PE Ratio
1.47
Return On Assets TTM
39.20 %
PEG Ratio
–
Return On Equity TTM
23.74 %
Wall Street Target Price
22.82 CHF
Revenue TTM
112 938 171 CHF
Book Value
4.08 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
258.30 %
Dividend Yield
–
Gross Profit TTM
-5 331 277 CHF
Earnings per share
5.72 CHF
Diluted Eps TTM
5.72 CHF
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
55.34 %
Dividend Analytics SANN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History SANN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.07.2023
Dividend Date
08.09.2022
Stock Valuation SANN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
1.47
Forward PE
–
Enterprise Value Revenue
1.55
Price Sales TTM
1.42
Enterprise Value EBITDA
2.08
Price Book MRQ
3.45
Financials SANN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SANN
For 52 weeks
7.17 CHF
15.73 CHF
50 Day MA
9.02 CHF
Shares Short Prior Month
–
200 Day MA
9.26 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart